Alliancebernstein L.P. Vista Gen Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.09 - $0.16 $12,348 - $21,952	137,200 Added 76.78%	315,900 $31,000
Q3 2022 Nov 15, 2022	BUY	$0.14 - $1.07 $20,384 - $155,792	145,600 Added 439.88%	178,700 $27,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.73 $10,120 - $19,895	11,500 Added 53.24%	33,100 $29,000
Q1 2022 May 13, 2022	SELL	$1.14 - $2.09 $20,520 - $37,620	-18,000 Reduced 45.45%	21,600 $27,000
Q2 2021 Jul 30, 2021	BUY	$1.96 - $3.15 $77,616 - $124,740	39,600 New	39,600 $125,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.